nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—CYP3A4—type 2 diabetes mellitus	0.12	0.534	CbGaD
Cephalexin—ALB—type 2 diabetes mellitus	0.104	0.466	CbGaD
Cephalexin—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.0408	0.0705	CbGbCtD
Cephalexin—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0364	0.0629	CbGbCtD
Cephalexin—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0351	0.0608	CbGbCtD
Cephalexin—SLC47A1—Metformin—type 2 diabetes mellitus	0.0325	0.0562	CbGbCtD
Cephalexin—SLC15A2—Ramipril—type 2 diabetes mellitus	0.0324	0.056	CbGbCtD
Cephalexin—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0313	0.0541	CbGbCtD
Cephalexin—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0309	0.0535	CbGbCtD
Cephalexin—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0279	0.0483	CbGbCtD
Cephalexin—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0266	0.046	CbGbCtD
Cephalexin—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0209	0.0361	CbGbCtD
Cephalexin—ALB—Gliclazide—type 2 diabetes mellitus	0.0194	0.0335	CbGbCtD
Cephalexin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0194	0.0335	CbGbCtD
Cephalexin—ALB—Repaglinide—type 2 diabetes mellitus	0.0182	0.0315	CbGbCtD
Cephalexin—SLC15A1—Glyburide—type 2 diabetes mellitus	0.018	0.0311	CbGbCtD
Cephalexin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0173	0.0298	CbGbCtD
Cephalexin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0152	0.0263	CbGbCtD
Cephalexin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0147	0.0254	CbGbCtD
Cephalexin—ALB—Valsartan—type 2 diabetes mellitus	0.0134	0.0232	CbGbCtD
Cephalexin—ALB—Nateglinide—type 2 diabetes mellitus	0.0125	0.0216	CbGbCtD
Cephalexin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00991	0.0171	CbGbCtD
Cephalexin—SLC22A6—Losartan—type 2 diabetes mellitus	0.00907	0.0157	CbGbCtD
Cephalexin—ALB—Glyburide—type 2 diabetes mellitus	0.00844	0.0146	CbGbCtD
Cephalexin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00813	0.0141	CbGbCtD
Cephalexin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00802	0.0139	CbGbCtD
Cephalexin—ALB—Losartan—type 2 diabetes mellitus	0.00772	0.0133	CbGbCtD
Cephalexin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0075	0.013	CbGbCtD
Cephalexin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00715	0.0124	CbGbCtD
Cephalexin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00654	0.0113	CbGbCtD
Cephalexin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00616	0.0106	CbGbCtD
Cephalexin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00591	0.0102	CbGbCtD
Cephalexin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00572	0.00988	CbGbCtD
Cephalexin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00517	0.00894	CbGbCtD
Cephalexin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00392	0.00677	CbGbCtD
Cephalexin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00376	0.00649	CbGbCtD
Cephalexin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00376	0.00649	CbGbCtD
Cephalexin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00355	0.00614	CbGbCtD
Cephalexin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00265	0.00457	CbGbCtD
Cephalexin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00242	0.00418	CbGbCtD
Cephalexin—Cefazolin—PON1—type 2 diabetes mellitus	0.000602	0.51	CrCbGaD
Cephalexin—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000333	0.0704	CbGeAlD
Cephalexin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000285	0.0603	CbGeAlD
Cephalexin—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000277	0.0586	CbGeAlD
Cephalexin—SLC47A1—nephron tubule—type 2 diabetes mellitus	0.00026	0.055	CbGeAlD
Cephalexin—SLC15A1—kidney—type 2 diabetes mellitus	0.000244	0.0515	CbGeAlD
Cephalexin—SLC47A1—kidney—type 2 diabetes mellitus	0.000229	0.0483	CbGeAlD
Cephalexin—SLC47A1—cortex of kidney—type 2 diabetes mellitus	0.000223	0.047	CbGeAlD
Cephalexin—SLC47A1—adipose tissue—type 2 diabetes mellitus	0.000206	0.0435	CbGeAlD
Cephalexin—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000199	0.0422	CbGeAlD
Cephalexin—SLC15A2—retina—type 2 diabetes mellitus	0.000184	0.0389	CbGeAlD
Cephalexin—SLC22A8—kidney—type 2 diabetes mellitus	0.000175	0.037	CbGeAlD
Cephalexin—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000173	0.0366	CbGeAlD
Cephalexin—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000171	0.0361	CbGeAlD
Cephalexin—SLC22A5—retina—type 2 diabetes mellitus	0.00016	0.0338	CbGeAlD
Cephalexin—Cefpiramide—ALB—type 2 diabetes mellitus	0.000159	0.135	CrCbGaD
Cephalexin—SLC15A1—liver—type 2 diabetes mellitus	0.000154	0.0326	CbGeAlD
Cephalexin—SLC15A2—kidney—type 2 diabetes mellitus	0.000152	0.0322	CbGeAlD
Cephalexin—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000151	0.0319	CbGeAlD
Cephalexin—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000148	0.0314	CbGeAlD
Cephalexin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000147	0.00104	CcSEcCtD
Cephalexin—Angioedema—Valsartan—type 2 diabetes mellitus	0.000146	0.00103	CcSEcCtD
Cephalexin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000146	0.00103	CcSEcCtD
Cephalexin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000145	0.00102	CcSEcCtD
Cephalexin—Angioedema—Orlistat—type 2 diabetes mellitus	0.000145	0.00102	CcSEcCtD
Cephalexin—SLC47A1—liver—type 2 diabetes mellitus	0.000144	0.0305	CbGeAlD
Cephalexin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000144	0.00102	CcSEcCtD
Cephalexin—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Cephalexin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Cephalexin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000143	0.00101	CcSEcCtD
Cephalexin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000142	0.000997	CcSEcCtD
Cephalexin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000141	0.000996	CcSEcCtD
Cephalexin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000141	0.000996	CcSEcCtD
Cephalexin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000141	0.000993	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000141	0.000992	CcSEcCtD
Cephalexin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000141	0.000991	CcSEcCtD
Cephalexin—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000141	0.00099	CcSEcCtD
Cephalexin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00014	0.000983	CcSEcCtD
Cephalexin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000139	0.000982	CcSEcCtD
Cephalexin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000139	0.000982	CcSEcCtD
Cephalexin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000139	0.00098	CcSEcCtD
Cephalexin—Cefonicid—ALB—type 2 diabetes mellitus	0.000138	0.117	CrCbGaD
Cephalexin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000138	0.000973	CcSEcCtD
Cephalexin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000138	0.00097	CcSEcCtD
Cephalexin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000969	CcSEcCtD
Cephalexin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000137	0.000967	CcSEcCtD
Cephalexin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000137	0.000965	CcSEcCtD
Cephalexin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000964	CcSEcCtD
Cephalexin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000137	0.000964	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000137	0.000963	CcSEcCtD
Cephalexin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000136	0.00096	CcSEcCtD
Cephalexin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000136	0.000958	CcSEcCtD
Cephalexin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000136	0.000957	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000135	0.000953	CcSEcCtD
Cephalexin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000135	0.00095	CcSEcCtD
Cephalexin—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000134	0.000946	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000134	0.000942	CcSEcCtD
Cephalexin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000133	0.000933	CcSEcCtD
Cephalexin—SLC22A5—kidney—type 2 diabetes mellitus	0.000133	0.028	CbGeAlD
Cephalexin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000131	0.000925	CcSEcCtD
Cephalexin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000131	0.000922	CcSEcCtD
Cephalexin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000131	0.000921	CcSEcCtD
Cephalexin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000131	0.00092	CcSEcCtD
Cephalexin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00013	0.000919	CcSEcCtD
Cephalexin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00013	0.000918	CcSEcCtD
Cephalexin—Rash—Glipizide—type 2 diabetes mellitus	0.00013	0.000913	CcSEcCtD
Cephalexin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00013	0.000913	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00013	0.000912	CcSEcCtD
Cephalexin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000129	0.000912	CcSEcCtD
Cephalexin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000129	0.000909	CcSEcCtD
Cephalexin—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000129	0.0273	CbGeAlD
Cephalexin—Headache—Glipizide—type 2 diabetes mellitus	0.000129	0.000908	CcSEcCtD
Cephalexin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000128	0.000902	CcSEcCtD
Cephalexin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000128	0.000901	CcSEcCtD
Cephalexin—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000128	0.000898	CcSEcCtD
Cephalexin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000127	0.000894	CcSEcCtD
Cephalexin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000127	0.000893	CcSEcCtD
Cephalexin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000127	0.000891	CcSEcCtD
Cephalexin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000127	0.000891	CcSEcCtD
Cephalexin—Agitation—Irbesartan—type 2 diabetes mellitus	0.000126	0.00089	CcSEcCtD
Cephalexin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000126	0.000886	CcSEcCtD
Cephalexin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000126	0.000885	CcSEcCtD
Cephalexin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000125	0.000883	CcSEcCtD
Cephalexin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000125	0.000882	CcSEcCtD
Cephalexin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000125	0.000881	CcSEcCtD
Cephalexin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000125	0.000881	CcSEcCtD
Cephalexin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000124	0.000875	CcSEcCtD
Cephalexin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000123	0.00087	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000123	0.000868	CcSEcCtD
Cephalexin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000867	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000123	0.000864	CcSEcCtD
Cephalexin—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000123	0.000863	CcSEcCtD
Cephalexin—Nausea—Glipizide—type 2 diabetes mellitus	0.000122	0.000861	CcSEcCtD
Cephalexin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000122	0.00086	CcSEcCtD
Cephalexin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000122	0.000857	CcSEcCtD
Cephalexin—Rash—Glimepiride—type 2 diabetes mellitus	0.000121	0.000852	CcSEcCtD
Cephalexin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000121	0.000852	CcSEcCtD
Cephalexin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000121	0.00085	CcSEcCtD
Cephalexin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000849	CcSEcCtD
Cephalexin—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000121	0.000849	CcSEcCtD
Cephalexin—Headache—Glimepiride—type 2 diabetes mellitus	0.00012	0.000847	CcSEcCtD
Cephalexin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00012	0.000844	CcSEcCtD
Cephalexin—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000119	0.0252	CbGeAlD
Cephalexin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000119	0.000838	CcSEcCtD
Cephalexin—Agitation—Losartan—type 2 diabetes mellitus	0.000119	0.000838	CcSEcCtD
Cephalexin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000119	0.000835	CcSEcCtD
Cephalexin—Angioedema—Losartan—type 2 diabetes mellitus	0.000118	0.000833	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000118	0.000828	CcSEcCtD
Cephalexin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000117	0.000825	CcSEcCtD
Cephalexin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000825	CcSEcCtD
Cephalexin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000117	0.000821	CcSEcCtD
Cephalexin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000117	0.000821	CcSEcCtD
Cephalexin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000116	0.00082	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000116	0.000819	CcSEcCtD
Cephalexin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.000819	CcSEcCtD
Cephalexin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000116	0.000816	CcSEcCtD
Cephalexin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000116	0.000814	CcSEcCtD
Cephalexin—ALB—liver—type 2 diabetes mellitus	0.000115	0.0244	CbGeAlD
Cephalexin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000811	CcSEcCtD
Cephalexin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000115	0.00081	CcSEcCtD
Cephalexin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000115	0.000807	CcSEcCtD
Cephalexin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000114	0.000803	CcSEcCtD
Cephalexin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000114	0.000801	CcSEcCtD
Cephalexin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000114	0.0008	CcSEcCtD
Cephalexin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000114	0.0008	CcSEcCtD
Cephalexin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000113	0.000795	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000113	0.000794	CcSEcCtD
Cephalexin—Fatigue—Valsartan—type 2 diabetes mellitus	0.000113	0.000793	CcSEcCtD
Cephalexin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000112	0.000791	CcSEcCtD
Cephalexin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000112	0.000791	CcSEcCtD
Cephalexin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000112	0.000791	CcSEcCtD
Cephalexin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000112	0.000789	CcSEcCtD
Cephalexin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000787	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000111	0.000785	CcSEcCtD
Cephalexin—Fatigue—Orlistat—type 2 diabetes mellitus	0.000111	0.000784	CcSEcCtD
Cephalexin—Arthralgia—Losartan—type 2 diabetes mellitus	0.00011	0.000776	CcSEcCtD
Cephalexin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000776	CcSEcCtD
Cephalexin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00011	0.000775	CcSEcCtD
Cephalexin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00011	0.000774	CcSEcCtD
Cephalexin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000769	CcSEcCtD
Cephalexin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000768	CcSEcCtD
Cephalexin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000109	0.000768	CcSEcCtD
Cephalexin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000109	0.000764	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000108	0.000763	CcSEcCtD
Cephalexin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000108	0.000763	CcSEcCtD
Cephalexin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000107	0.000752	CcSEcCtD
Cephalexin—Confusional state—Losartan—type 2 diabetes mellitus	0.000107	0.00075	CcSEcCtD
Cephalexin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000106	0.000749	CcSEcCtD
Cephalexin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000106	0.000744	CcSEcCtD
Cephalexin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000106	0.000743	CcSEcCtD
Cephalexin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000105	0.000738	CcSEcCtD
Cephalexin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000105	0.000737	CcSEcCtD
Cephalexin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000104	0.000731	CcSEcCtD
Cephalexin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000104	0.00073	CcSEcCtD
Cephalexin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000103	0.000728	CcSEcCtD
Cephalexin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000103	0.000727	CcSEcCtD
Cephalexin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000103	0.000724	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000103	0.000723	CcSEcCtD
Cephalexin—Fatigue—Metformin—type 2 diabetes mellitus	0.000103	0.000722	CcSEcCtD
Cephalexin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000103	0.000722	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000102	0.00072	CcSEcCtD
Cephalexin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000102	0.000719	CcSEcCtD
Cephalexin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000102	0.000719	CcSEcCtD
Cephalexin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000102	0.000718	CcSEcCtD
Cephalexin—Agitation—Ramipril—type 2 diabetes mellitus	0.000102	0.000718	CcSEcCtD
Cephalexin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000101	0.000714	CcSEcCtD
Cephalexin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000101	0.000709	CcSEcCtD
Cephalexin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000101	0.000708	CcSEcCtD
Cephalexin—Rash—Glyburide—type 2 diabetes mellitus	9.98e-05	0.000703	CcSEcCtD
Cephalexin—Dermatitis—Glyburide—type 2 diabetes mellitus	9.98e-05	0.000702	CcSEcCtD
Cephalexin—Leukopenia—Ramipril—type 2 diabetes mellitus	9.94e-05	0.0007	CcSEcCtD
Cephalexin—Headache—Glyburide—type 2 diabetes mellitus	9.92e-05	0.000699	CcSEcCtD
Cephalexin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	9.88e-05	0.000696	CcSEcCtD
Cephalexin—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.8e-05	0.00069	CcSEcCtD
Cephalexin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.000685	CcSEcCtD
Cephalexin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.73e-05	0.000685	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.000682	CcSEcCtD
Cephalexin—Fatigue—Irbesartan—type 2 diabetes mellitus	9.68e-05	0.000682	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.63e-05	0.000678	CcSEcCtD
Cephalexin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.63e-05	0.000678	CcSEcCtD
Cephalexin—Convulsion—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000677	CcSEcCtD
Cephalexin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.51e-05	0.00067	CcSEcCtD
Cephalexin—Urticaria—Metformin—type 2 diabetes mellitus	9.45e-05	0.000665	CcSEcCtD
Cephalexin—Arthralgia—Ramipril—type 2 diabetes mellitus	9.45e-05	0.000665	CcSEcCtD
Cephalexin—Nausea—Glyburide—type 2 diabetes mellitus	9.41e-05	0.000662	CcSEcCtD
Cephalexin—Abdominal pain—Metformin—type 2 diabetes mellitus	9.4e-05	0.000662	CcSEcCtD
Cephalexin—Dizziness—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000662	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000661	CcSEcCtD
Cephalexin—Asthenia—Valsartan—type 2 diabetes mellitus	9.37e-05	0.00066	CcSEcCtD
Cephalexin—Dyspepsia—Losartan—type 2 diabetes mellitus	9.3e-05	0.000655	CcSEcCtD
Cephalexin—Asthenia—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000652	CcSEcCtD
Cephalexin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.25e-05	0.000651	CcSEcCtD
Cephalexin—Pruritus—Valsartan—type 2 diabetes mellitus	9.24e-05	0.000651	CcSEcCtD
Cephalexin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000646	CcSEcCtD
Cephalexin—Confusional state—Ramipril—type 2 diabetes mellitus	9.14e-05	0.000643	CcSEcCtD
Cephalexin—Pruritus—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000643	CcSEcCtD
Cephalexin—Fatigue—Losartan—type 2 diabetes mellitus	9.11e-05	0.000641	CcSEcCtD
Cephalexin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000638	CcSEcCtD
Cephalexin—Vomiting—Gliclazide—type 2 diabetes mellitus	9.04e-05	0.000637	CcSEcCtD
Cephalexin—Rash—Gliclazide—type 2 diabetes mellitus	8.97e-05	0.000631	CcSEcCtD
Cephalexin—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.96e-05	0.000631	CcSEcCtD
Cephalexin—Cefradine—CYP3A4—type 2 diabetes mellitus	8.95e-05	0.0759	CrCbGaD
Cephalexin—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.94e-05	0.000629	CcSEcCtD
Cephalexin—Urticaria—Irbesartan—type 2 diabetes mellitus	8.92e-05	0.000628	CcSEcCtD
Cephalexin—Headache—Gliclazide—type 2 diabetes mellitus	8.91e-05	0.000627	CcSEcCtD
Cephalexin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000626	CcSEcCtD
Cephalexin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000625	CcSEcCtD
Cephalexin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.88e-05	0.000625	CcSEcCtD
Cephalexin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	8.87e-05	0.000625	CcSEcCtD
Cephalexin—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000622	CcSEcCtD
Cephalexin—Skin disorder—Ramipril—type 2 diabetes mellitus	8.8e-05	0.00062	CcSEcCtD
Cephalexin—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.71e-05	0.000613	CcSEcCtD
Cephalexin—CYP3A4—kidney—type 2 diabetes mellitus	8.69e-05	0.0184	CbGeAlD
Cephalexin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.64e-05	0.000608	CcSEcCtD
Cephalexin—Dizziness—Valsartan—type 2 diabetes mellitus	8.64e-05	0.000608	CcSEcCtD
Cephalexin—CYP2D6—kidney—type 2 diabetes mellitus	8.55e-05	0.0181	CbGeAlD
Cephalexin—Dizziness—Orlistat—type 2 diabetes mellitus	8.54e-05	0.000601	CcSEcCtD
Cephalexin—Asthenia—Metformin—type 2 diabetes mellitus	8.54e-05	0.000601	CcSEcCtD
Cephalexin—Nausea—Gliclazide—type 2 diabetes mellitus	8.45e-05	0.000595	CcSEcCtD
Cephalexin—Pruritus—Metformin—type 2 diabetes mellitus	8.42e-05	0.000593	CcSEcCtD
Cephalexin—Urticaria—Losartan—type 2 diabetes mellitus	8.39e-05	0.000591	CcSEcCtD
Cephalexin—SLC22A5—liver—type 2 diabetes mellitus	8.38e-05	0.0177	CbGeAlD
Cephalexin—Abdominal pain—Losartan—type 2 diabetes mellitus	8.35e-05	0.000588	CcSEcCtD
Cephalexin—Body temperature increased—Losartan—type 2 diabetes mellitus	8.35e-05	0.000588	CcSEcCtD
Cephalexin—Vomiting—Valsartan—type 2 diabetes mellitus	8.31e-05	0.000585	CcSEcCtD
Cephalexin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000582	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000581	CcSEcCtD
Cephalexin—Rash—Valsartan—type 2 diabetes mellitus	8.24e-05	0.00058	CcSEcCtD
Cephalexin—Dermatitis—Valsartan—type 2 diabetes mellitus	8.23e-05	0.000579	CcSEcCtD
Cephalexin—Vomiting—Orlistat—type 2 diabetes mellitus	8.21e-05	0.000578	CcSEcCtD
Cephalexin—Headache—Valsartan—type 2 diabetes mellitus	8.18e-05	0.000576	CcSEcCtD
Cephalexin—Diarrhoea—Metformin—type 2 diabetes mellitus	8.14e-05	0.000573	CcSEcCtD
Cephalexin—Rash—Orlistat—type 2 diabetes mellitus	8.14e-05	0.000573	CcSEcCtD
Cephalexin—Dermatitis—Orlistat—type 2 diabetes mellitus	8.13e-05	0.000573	CcSEcCtD
Cephalexin—Headache—Orlistat—type 2 diabetes mellitus	8.09e-05	0.000569	CcSEcCtD
Cephalexin—Asthenia—Irbesartan—type 2 diabetes mellitus	8.06e-05	0.000567	CcSEcCtD
Cephalexin—Dyspepsia—Ramipril—type 2 diabetes mellitus	7.97e-05	0.000562	CcSEcCtD
Cephalexin—Pruritus—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.000559	CcSEcCtD
Cephalexin—Dizziness—Metformin—type 2 diabetes mellitus	7.87e-05	0.000554	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000551	CcSEcCtD
Cephalexin—Fatigue—Ramipril—type 2 diabetes mellitus	7.81e-05	0.00055	CcSEcCtD
Cephalexin—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.78e-05	0.000548	CcSEcCtD
Cephalexin—Nausea—Valsartan—type 2 diabetes mellitus	7.76e-05	0.000546	CcSEcCtD
Cephalexin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000541	CcSEcCtD
Cephalexin—Nausea—Orlistat—type 2 diabetes mellitus	7.67e-05	0.00054	CcSEcCtD
Cephalexin—Asthenia—Losartan—type 2 diabetes mellitus	7.58e-05	0.000534	CcSEcCtD
Cephalexin—Vomiting—Metformin—type 2 diabetes mellitus	7.56e-05	0.000533	CcSEcCtD
Cephalexin—Rash—Metformin—type 2 diabetes mellitus	7.5e-05	0.000528	CcSEcCtD
Cephalexin—Dermatitis—Metformin—type 2 diabetes mellitus	7.49e-05	0.000528	CcSEcCtD
Cephalexin—Pruritus—Losartan—type 2 diabetes mellitus	7.48e-05	0.000526	CcSEcCtD
Cephalexin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000526	CcSEcCtD
Cephalexin—Headache—Metformin—type 2 diabetes mellitus	7.45e-05	0.000525	CcSEcCtD
Cephalexin—Dizziness—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000523	CcSEcCtD
Cephalexin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000522	CcSEcCtD
Cephalexin—Diarrhoea—Losartan—type 2 diabetes mellitus	7.23e-05	0.000509	CcSEcCtD
Cephalexin—Urticaria—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000507	CcSEcCtD
Cephalexin—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000504	CcSEcCtD
Cephalexin—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000504	CcSEcCtD
Cephalexin—Vomiting—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000503	CcSEcCtD
Cephalexin—Rash—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000498	CcSEcCtD
Cephalexin—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000498	CcSEcCtD
Cephalexin—Nausea—Metformin—type 2 diabetes mellitus	7.07e-05	0.000498	CcSEcCtD
Cephalexin—Headache—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.000495	CcSEcCtD
Cephalexin—Dizziness—Losartan—type 2 diabetes mellitus	6.99e-05	0.000492	CcSEcCtD
Cephalexin—Ampicillin—ALB—type 2 diabetes mellitus	6.93e-05	0.0587	CrCbGaD
Cephalexin—Vomiting—Losartan—type 2 diabetes mellitus	6.72e-05	0.000473	CcSEcCtD
Cephalexin—Cefazolin—ALB—type 2 diabetes mellitus	6.69e-05	0.0568	CrCbGaD
Cephalexin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.67e-05	0.00047	CcSEcCtD
Cephalexin—Nausea—Irbesartan—type 2 diabetes mellitus	6.67e-05	0.00047	CcSEcCtD
Cephalexin—Rash—Losartan—type 2 diabetes mellitus	6.66e-05	0.000469	CcSEcCtD
Cephalexin—Dermatitis—Losartan—type 2 diabetes mellitus	6.66e-05	0.000469	CcSEcCtD
Cephalexin—Headache—Losartan—type 2 diabetes mellitus	6.62e-05	0.000466	CcSEcCtD
Cephalexin—Asthenia—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000458	CcSEcCtD
Cephalexin—Pruritus—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000451	CcSEcCtD
Cephalexin—Nausea—Losartan—type 2 diabetes mellitus	6.28e-05	0.000442	CcSEcCtD
Cephalexin—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000436	CcSEcCtD
Cephalexin—Dizziness—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000422	CcSEcCtD
Cephalexin—Vomiting—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000406	CcSEcCtD
Cephalexin—Rash—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000402	CcSEcCtD
Cephalexin—Dermatitis—Ramipril—type 2 diabetes mellitus	5.71e-05	0.000402	CcSEcCtD
Cephalexin—Headache—Ramipril—type 2 diabetes mellitus	5.68e-05	0.0004	CcSEcCtD
Cephalexin—Cefalotin—ALB—type 2 diabetes mellitus	5.56e-05	0.0471	CrCbGaD
Cephalexin—CYP3A4—liver—type 2 diabetes mellitus	5.49e-05	0.0116	CbGeAlD
Cephalexin—CYP2D6—liver—type 2 diabetes mellitus	5.4e-05	0.0114	CbGeAlD
Cephalexin—Nausea—Ramipril—type 2 diabetes mellitus	5.38e-05	0.000379	CcSEcCtD
Cephalexin—ALB—Metabolism—CBS—type 2 diabetes mellitus	1.05e-05	0.000211	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—APOB—type 2 diabetes mellitus	1.04e-05	0.000209	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	1.03e-05	0.000207	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC5A2—type 2 diabetes mellitus	1.01e-05	0.000203	CbGpPWpGaD
Cephalexin—ALB—Metabolism—COX2—type 2 diabetes mellitus	1.01e-05	0.000203	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NCOA6—type 2 diabetes mellitus	9.96e-06	0.0002	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	9.95e-06	0.0002	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	9.9e-06	0.000199	CbGpPWpGaD
Cephalexin—ALB—Metabolism—UCP2—type 2 diabetes mellitus	9.79e-06	0.000196	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HSD11B1—type 2 diabetes mellitus	9.79e-06	0.000196	CbGpPWpGaD
Cephalexin—ALB—Metabolism—UCP3—type 2 diabetes mellitus	9.79e-06	0.000196	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	9.75e-06	0.000196	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	9.75e-06	0.000196	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	9.5e-06	0.000191	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.49e-06	0.00019	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.46e-06	0.00019	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CD36—type 2 diabetes mellitus	9.46e-06	0.00019	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.42e-06	0.000189	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PPP2CA—type 2 diabetes mellitus	9.34e-06	0.000187	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.33e-06	0.000187	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PCK1—type 2 diabetes mellitus	9.2e-06	0.000185	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	9.07e-06	0.000182	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	9.07e-06	0.000182	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	9.07e-06	0.000182	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.06e-06	0.000182	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.02e-06	0.000181	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—SRC—type 2 diabetes mellitus	8.97e-06	0.00018	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.84e-06	0.000177	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—VEGFA—type 2 diabetes mellitus	8.73e-06	0.000175	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	8.69e-06	0.000174	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	8.69e-06	0.000174	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	8.65e-06	0.000174	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	8.65e-06	0.000174	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—MMP1—type 2 diabetes mellitus	8.62e-06	0.000173	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HK1—type 2 diabetes mellitus	8.62e-06	0.000173	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.61e-06	0.000173	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.43e-06	0.000169	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—CALM1—type 2 diabetes mellitus	8.37e-06	0.000168	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	8.37e-06	0.000168	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	8.37e-06	0.000168	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GCKR—type 2 diabetes mellitus	8.32e-06	0.000167	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HSD3B2—type 2 diabetes mellitus	8.32e-06	0.000167	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LPA—type 2 diabetes mellitus	8.32e-06	0.000167	CbGpPWpGaD
Cephalexin—ALB—Metabolism—KCNJ11—type 2 diabetes mellitus	8.32e-06	0.000167	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—APOA1—type 2 diabetes mellitus	8.25e-06	0.000165	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	8.22e-06	0.000165	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.2e-06	0.000165	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.2e-06	0.000165	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	8.08e-06	0.000162	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	8.08e-06	0.000162	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	8.08e-06	0.000162	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—TGFB1—type 2 diabetes mellitus	8.02e-06	0.000161	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8e-06	0.000161	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ALDOB—type 2 diabetes mellitus	7.98e-06	0.00016	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PRKCB—type 2 diabetes mellitus	7.87e-06	0.000158	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	7.82e-06	0.000157	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS2—type 2 diabetes mellitus	7.77e-06	0.000156	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.75e-06	0.000155	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.61e-06	0.000153	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	7.6e-06	0.000152	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.59e-06	0.000152	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.51e-06	0.000151	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GLP1R—type 2 diabetes mellitus	7.42e-06	0.000149	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.22e-06	0.000145	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.22e-06	0.000145	CbGpPWpGaD
Cephalexin—ALB—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.14e-06	0.000143	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	7.12e-06	0.000143	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	6.97e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	6.97e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	6.97e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.97e-06	0.00014	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	6.97e-06	0.00014	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC2A2—type 2 diabetes mellitus	6.93e-06	0.000139	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—IGF1—type 2 diabetes mellitus	6.89e-06	0.000138	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT2—type 2 diabetes mellitus	6.89e-06	0.000138	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	6.87e-06	0.000138	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	6.87e-06	0.000138	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	6.87e-06	0.000138	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	6.87e-06	0.000138	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	6.78e-06	0.000136	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTR—type 2 diabetes mellitus	6.78e-06	0.000136	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.75e-06	0.000135	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.65e-06	0.000133	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.61e-06	0.000133	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.61e-06	0.000133	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.61e-06	0.000133	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.61e-06	0.000133	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.59e-06	0.000132	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.57e-06	0.000132	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.55e-06	0.000131	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.45e-06	0.000129	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.38e-06	0.000128	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.38e-06	0.000128	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.38e-06	0.000128	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	6.25e-06	0.000125	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	6.25e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.21e-06	0.000125	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	6.12e-06	0.000123	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.93e-06	0.000119	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.82e-06	0.000117	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.77e-06	0.000116	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.72e-06	0.000115	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.69e-06	0.000114	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.68e-06	0.000114	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.68e-06	0.000114	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.65e-06	0.000113	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.6e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.6e-06	0.000112	CbGpPWpGaD
Cephalexin—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.57e-06	0.000112	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.49e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.47e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.47e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.46e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.46e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.46e-06	0.00011	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.43e-06	0.000109	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.42e-06	0.000109	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.37e-06	0.000108	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.36e-06	0.000108	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.36e-06	0.000108	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.33e-06	0.000107	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.28e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.28e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.28e-06	0.000106	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.27e-06	0.000106	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5.23e-06	0.000105	CbGpPWpGaD
Cephalexin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.2e-06	0.000104	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.14e-06	0.000103	CbGpPWpGaD
Cephalexin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.14e-06	0.000103	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.97e-06	9.97e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.9e-06	9.82e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.9e-06	9.82e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.9e-06	9.82e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.81e-06	9.64e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.76e-06	9.56e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.66e-06	9.35e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.65e-06	9.33e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.62e-06	9.27e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.5e-06	9.03e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.49e-06	9.01e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.49e-06	9.01e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.49e-06	9.01e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.49e-06	9.01e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.48e-06	8.98e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.43e-06	8.89e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.43e-06	8.89e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.43e-06	8.88e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.43e-06	8.88e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.41e-06	8.85e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.35e-06	8.73e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.32e-06	8.66e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.31e-06	8.64e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.25e-06	8.52e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.25e-06	8.52e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.23e-06	8.48e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.13e-06	8.29e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.11e-06	8.25e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.03e-06	8.09e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4e-06	8.03e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.95e-06	7.92e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.94e-06	7.9e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.83e-06	7.69e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.79e-06	7.59e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.74e-06	7.5e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.66e-06	7.35e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.66e-06	7.35e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.66e-06	7.34e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.66e-06	7.34e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.64e-06	7.31e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.63e-06	7.29e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.59e-06	7.21e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.59e-06	7.21e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.57e-06	7.16e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.57e-06	7.16e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.57e-06	7.16e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.56e-06	7.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.55e-06	7.12e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.49e-06	7e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.48e-06	6.99e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.45e-06	6.92e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.44e-06	6.91e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.39e-06	6.81e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.39e-06	6.81e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.38e-06	6.79e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.34e-06	6.71e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.33e-06	6.68e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.26e-06	6.54e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.25e-06	6.52e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.2e-06	6.42e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.2e-06	6.42e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.2e-06	6.42e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.17e-06	6.35e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.14e-06	6.3e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.13e-06	6.27e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.11e-06	6.25e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.05e-06	6.11e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3e-06	6.02e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.95e-06	5.91e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.94e-06	5.9e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.93e-06	5.87e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.9e-06	5.81e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.9e-06	5.81e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	5.8e-05	CbGpPWpGaD
Cephalexin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.87e-06	5.76e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.85e-06	5.72e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.8e-06	5.62e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.79e-06	5.6e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.78e-06	5.57e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.78e-06	5.57e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.76e-06	5.54e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.53e-06	5.08e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.53e-06	5.08e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.43e-06	4.88e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.39e-06	4.8e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.39e-06	4.8e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.39e-06	4.79e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.38e-06	4.78e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.35e-06	4.71e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	4.65e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.28e-06	4.58e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.22e-06	4.45e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.19e-06	4.39e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.18e-06	4.37e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.13e-06	4.28e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.12e-06	4.26e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.09e-06	4.2e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.09e-06	4.2e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.07e-06	4.15e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.04e-06	4.1e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.96e-06	3.93e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.92e-06	3.86e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	3.84e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.86e-06	3.74e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.83e-06	3.68e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.83e-06	3.66e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.8e-06	3.62e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.59e-06	3.19e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.56e-06	3.13e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.43e-06	2.87e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.37e-06	2.74e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.37e-06	2.74e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.25e-06	2.51e-05	CbGpPWpGaD
Cephalexin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	2.34e-05	CbGpPWpGaD
Cephalexin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.62e-07	1.93e-05	CbGpPWpGaD
Cephalexin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.29e-07	1.26e-05	CbGpPWpGaD
